BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27272814)

  • 1. ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Chen YL; Chen PM; Lin PY; Hsiau YT; Chu PY
    Anticancer Res; 2016 Jun; 36(6):2983-8. PubMed ID: 27272814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.
    Zen Y; Fujii T; Yoshikawa S; Takamura H; Tani T; Ohta T; Nakanuma Y
    Am J Pathol; 2007 May; 170(5):1750-62. PubMed ID: 17456779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(4):367-76. PubMed ID: 23394449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
    Jing YY; Liu WT; Guo SW; Ye F; Fan QM; Yu GF; Yu DD; Gao L; Sun K; Han ZP; Li R; Yang Y; Zhao QD; Wu MC; Wang HY; Wei LX
    Oncotarget; 2015 Dec; 6(40):42952-62. PubMed ID: 26515593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
    Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
    Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
    BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of transporter associated with antigen processing 1 and tumor necrosis factor alpha expression in hepatitis B virus-related hepatocellular carcinoma and peritumor cirrhosis tissues using tissue chip technology.
    Qiu B; Jiang W; Zhang J; Wang Y; Wei F; Hu H; Zhang P; Shi C; Zhang J
    Hepatogastroenterology; 2013; 60(121):14-8. PubMed ID: 23682387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.
    Pan HZ; Dong AB; Wang L; Tan SS; Yang Q; Tong XY; Liang J; Wang JR
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1095-101. PubMed ID: 23661524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.